Renishaw plc’s (LON:RSW) Sell Rating Reiterated at Deutsche Bank AG
Renishaw plc (LON:RSW)‘s stock had its “sell” rating reissued by equities research analysts at Deutsche Bank AG in a research note issued on Monday. They presently have a GBX 3,180 ($41.95) target price on the stock. Deutsche Bank AG’s target price would indicate a potential downside of 28.14% from the stock’s current price.
A number of other research firms have also recently issued reports on RSW. Numis Securities Ltd cut Renishaw plc to a “hold” rating and set a GBX 3,700 ($48.81) target price for the company. in a research note on Wednesday, May 10th. Barclays PLC reissued an “underweight” rating on shares of Renishaw plc in a research note on Tuesday, April 25th. Two investment analysts have rated the stock with a sell rating and four have given a hold rating to the company. Renishaw plc has an average rating of “Hold” and an average price target of GBX 3,220.60 ($42.48).
Shares of Renishaw plc (LON RSW) traded up 2.67% on Monday, reaching GBX 4418.00. 61,996 shares of the company were exchanged. The stock’s market capitalization is GBX 3.22 billion. Renishaw plc has a 12 month low of GBX 2,340.48 and a 12 month high of GBX 4,434.00. The stock has a 50 day moving average price of GBX 3,809.64 and a 200-day moving average price of GBX 3,370.87.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/08/07/renishaw-plcs-lonrsw-sell-rating-reiterated-at-deutsche-bank-ag.html.
About Renishaw plc
Renishaw plc is a metrology company. The Company operates through two segments: metrology and healthcare. The Company’s metrology products are used in the fields of industrial automation and motion systems. The healthcare products include engineering solutions for stereotactic neurosurgery, diagnosis of infectious diseases, analytical tools that identify and characterize the chemistry and structure of materials, supply of implants to hospitals and specialist design centers for craniomaxillofacial surgery, and products and services that allow dental laboratories to manufacture dental restorations.
Receive News & Ratings for Renishaw plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renishaw plc and related companies with MarketBeat.com's FREE daily email newsletter.